NCT06755554View on ClinicalTrials.gov

Investigation of Impact of Indocyanine Green on Volume of Lymphadenectomy in Resectable Gastric Cancer

PHASE3RecruitingINTERVENTIONAL

Enrollment

105

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

January 1, 2026

Study Completion Date

February 1, 2026

Conditions

Gastric Cancer Stage IIGastric Cancer Stage IIIGastric CancerGastrectomy for Gastric Cancer

Interventions

DRUG

Endoscopic injection of Indocyanine green

ICG is injected by the patient by endoscopic submucosal injection into 4 points around the tumor 24-12 hours before the start of the surgical intervention.

Trial Locations (2)

03022

NOT_YET_RECRUITING

National Cancer Institute, Kyiv

RECRUITING

National Cancer Institute, Kyiv

All Listed Sponsors

lead

Ukrainian Society of Clinical Oncology

OTHER

NCT06755554 - Investigation of Impact of Indocyanine Green on Volume of Lymphadenectomy in Resectable Gastric Cancer | Biotech Hunter | Biotech Hunter